Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,865 | -3,713 | -1,740 | -1,200 | -1,250 |
| Depreciation Amortization | 53 | 2,042 | 0 | 90 | 40 |
| Accounts receivable | 58 | -50 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -210 | -86 | N/A | N/A | N/A |
| Other Working Capital | -166 | -481 | 0 | -280 | 270 |
| Other Operating Activity | 660 | -211 | 240 | 80 | 210 |
| Operating Cash Flow | $-2,470 | $-2,499 | $-1,500 | $-1,310 | $-730 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -84 | -6 | -10 | -10 |
| Net Acquisitions | N/A | N/A | 730 | 0 | 0 |
| Sale Of Investment | 291 | 3,054 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -2 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 1,216 | 366 | -1,924 | -1,360 | -90 |
| Investing Cash Flow | $1,499 | $3,336 | $-1,200 | $-1,370 | $-100 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 309 | 317 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 4,280 | 1,740 | 1,480 |
| Financing Cash Flow | $309 | $317 | $4,280 | $1,740 | $1,480 |
| Exchange Rate Effect | -14 | 37 | 5 | -3 | 10 |
| Beginning Cash Position | 2,887 | 1,696 | 120 | 1,060 | 410 |
| End Cash Position | 2,159 | 2,887 | 1,690 | 120 | 1,060 |
| Net Cash Flow | $-728 | $1,191 | $1,570 | $-940 | $650 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,470 | -2,499 | -1,500 | -1,310 | -730 |
| Capital Expenditure | -8 | -84 | N/A | N/A | N/A |
| Free Cash Flow | -2,478 | -2,583 | -1,500 | -1,310 | -730 |